413 related articles for article (PubMed ID: 13129414)
21. Costs and health-related quality of life of patients with cystic fibrosis and their carers in France.
Chevreul K; Berg Brigham K; Michel M; Rault G;
J Cyst Fibros; 2015 May; 14(3):384-91. PubMed ID: 25620688
[TBL] [Abstract][Full Text] [Related]
22. Economic aspects of pneumococcal pneumonia: a review of the literature.
De Graeve D; Beutels P
Pharmacoeconomics; 2004; 22(11):719-40. PubMed ID: 15250750
[TBL] [Abstract][Full Text] [Related]
23. Costs of treatment of adult patients with cystic fibrosis in Poland and internationally.
Kopciuch D; Zaprutko T; Paczkowska A; Nowakowska E
Public Health; 2017 Jul; 148():49-55. PubMed ID: 28404533
[TBL] [Abstract][Full Text] [Related]
24. The cost of medical care for patients with cystic fibrosis in a health maintenance organization.
Lieu TA; Ray GT; Farmer G; Shay GF
Pediatrics; 1999 Jun; 103(6):e72. PubMed ID: 10353969
[TBL] [Abstract][Full Text] [Related]
25. A Scoping Review of Healthcare Costs for Patients with Cystic Fibrosis.
Hollin IL; Robinson KA
Appl Health Econ Health Policy; 2016 Apr; 14(2):151-9. PubMed ID: 26649564
[TBL] [Abstract][Full Text] [Related]
26. Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis.
Durieu I; Dalon F; Reynaud Q; Lemonnier L; Dehillotte C; Bérard M; Walther D; Viprey M; Van Ganse E; Belhassen M
J Cyst Fibros; 2022 Jan; 21(1):88-95. PubMed ID: 33865726
[TBL] [Abstract][Full Text] [Related]
27. Hospitalisation costs of cystic fibrosis.
Schreyögg J; Hollmeyer H; Bluemel M; Staab D; Busse R
Pharmacoeconomics; 2006; 24(10):999-1009. PubMed ID: 17002482
[TBL] [Abstract][Full Text] [Related]
28. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.
Chevreul K; Michel M; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():7-18. PubMed ID: 27059622
[TBL] [Abstract][Full Text] [Related]
29. Cost of cystic fibrosis: analysis of treatment costs in a specialized center in northern Italy.
Colombo C; Daccò V; Alicandro G; Loi S; Mazzi S; Lucioni C; Ravasio R
Adv Ther; 2013 Feb; 30(2):165-75. PubMed ID: 23397400
[TBL] [Abstract][Full Text] [Related]
30. Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.
Abbott J; Gee L
Paediatr Drugs; 2003; 5(1):41-56. PubMed ID: 12513105
[TBL] [Abstract][Full Text] [Related]
31. Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network.
Huot L; Durieu I; Bourdy S; Ganne C; Bellon G; Colin C; Touzet S;
J Cyst Fibros; 2008 Sep; 7(5):403-8. PubMed ID: 18358793
[TBL] [Abstract][Full Text] [Related]
32. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
33. A cost-effectiveness analysis of rhDNase in children with cystic fibrosis.
Grieve R; Thompson S; Normand C; Suri R; Bush A; Wallis C
Int J Technol Assess Health Care; 2003; 19(1):71-9. PubMed ID: 12701940
[TBL] [Abstract][Full Text] [Related]
34. Hospitalization costs of cystic fibrosis in the United States: a retrospective analysis.
Vadagam P; Kamal KM
Hosp Pract (1995); 2018 Oct; 46(4):203-213. PubMed ID: 30067115
[TBL] [Abstract][Full Text] [Related]
35. [Cost comparison of hospital and ambulatory i.v. therapy in adult cystic fibrosis patients. Results of a controlled prospective study].
Krauth C; Busse R; Smaczny C; Ullrich G; Wagner TO; Weber J; Welte T
Med Klin (Munich); 1999 Oct; 94(10):541-8. PubMed ID: 10554512
[TBL] [Abstract][Full Text] [Related]
36. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
Suri R
BioDrugs; 2005; 19(3):135-44. PubMed ID: 15984899
[TBL] [Abstract][Full Text] [Related]
37. Comment: cost of rhDNase in cystic fibrosis.
Marra CA; Carleton BC; Basmadjian D; Levine M; McKerrow R
Ann Pharmacother; 1995 Oct; 29(10):1050-1. PubMed ID: 8845550
[No Abstract] [Full Text] [Related]
38. Assessing the cost of cystic fibrosis diagnosis and treatment.
Rosenberg MA; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S101-5. PubMed ID: 16202771
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness and cost-utility analyses of hospital-based home care compared to hospital-based care for children diagnosed with type 1 diabetes; a randomised controlled trial; results after two years' follow-up.
Tiberg I; Lindgren B; Carlsson A; Hallström I
BMC Pediatr; 2016 Jul; 16():94. PubMed ID: 27421262
[TBL] [Abstract][Full Text] [Related]
40. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients.
Kane RE; Jennison K; Wood C; Black PG; Herbst JJ
Pediatr Pulmonol; 1988; 4(2):84-9. PubMed ID: 3132695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
